Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Generation of transgene-free induced pluripotent stem cells with non-viral methods.

Wang T, Zhao HS, Zhang QL, Xu CL, Liu CB.

Chin Med Sci J. 2013 Mar;28(1):50-4. Review.

PMID:
23527808
2.

Non-viral methods for generating integration-free, induced pluripotent stem cells.

Deng XY, Wang H, Wang T, Fang XT, Zou LL, Li ZY, Liu CB.

Curr Stem Cell Res Ther. 2015;10(2):153-8. Review.

3.

Advances in reprogramming somatic cells to induced pluripotent stem cells.

Patel M, Yang S.

Stem Cell Rev. 2010 Sep;6(3):367-80. doi: 10.1007/s12015-010-9123-8. Review.

4.

Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector.

Chen MJ, Lu Y, Hamazaki T, Tsai HY, Erger K, Conlon T, Elshikha AS, Li H, Srivastava A, Yao C, Brantly M, Chiodo V, Hauswirth W, Terada N, Song S.

Hum Gene Ther Methods. 2014 Feb;25(1):72-82. doi: 10.1089/hgtb.2013.011. Epub 2013 Dec 28.

5.

Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.

Phang RZ, Tay FC, Goh SL, Lau CH, Zhu H, Tan WK, Liang Q, Chen C, Du S, Li Z, Tay JC, Wu C, Zeng J, Fan W, Toh HC, Wang S.

Stem Cells Transl Med. 2013 Dec;2(12):935-45. doi: 10.5966/sctm.2013-0043. Epub 2013 Oct 28.

6.

Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.

Chen LW, Kuang F, Wei LC, Ding YX, Yung KK, Chan YS.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):449-58. Review.

PMID:
21495962
7.

Emerging methods for preparing iPS cells.

Miyazaki S, Yamamoto H, Miyoshi N, Takahashi H, Suzuki Y, Haraguchi N, Ishii H, Doki Y, Mori M.

Jpn J Clin Oncol. 2012 Sep;42(9):773-9. doi: 10.1093/jjco/hys108. Epub 2012 Jul 23. Review.

PMID:
22826352
8.

Excision of a viral reprogramming cassette by delivery of synthetic Cre mRNA.

Loh YH, Yang JC, De Los Angeles A, Guo C, Cherry A, Rossi DJ, Park IH, Daley GQ.

Curr Protoc Stem Cell Biol. 2012;Chapter 4:Unit4A.5. doi: 10.1002/9780470151808.sc04a05s21.

9.

Mouse-induced pluripotent stem cells generated under hypoxic conditions in the absence of viral infection and oncogenic factors and used for ischemic stroke therapy.

Liu SP, Fu RH, Wu DC, Hsu CY, Chang CH, Lee W, Lee YD, Liu CH, Chien YJ, Lin SZ, Shyu WC.

Stem Cells Dev. 2014 Feb 15;23(4):421-33. doi: 10.1089/scd.2013.0182. Epub 2014 Jan 4.

PMID:
24266622
10.

Generation of Induced Pluripotent Stem Cells (iPSCs) from Adult Canine Fibroblasts.

Koh S, Piedrahita JA.

Methods Mol Biol. 2015;1330:69-78. doi: 10.1007/978-1-4939-2848-4_7.

PMID:
26621590
11.

The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.

Tat PA, Sumer H, Jones KL, Upton K, Verma PJ.

Cell Transplant. 2010;19(5):525-36. doi: 10.3727/096368910X491374. Epub 2010 Feb 8.

PMID:
20144262
12.

A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.

Li Y, Geng YJ.

Growth Horm IGF Res. 2010 Dec;20(6):391-8. doi: 10.1016/j.ghir.2010.09.005. Epub 2010 Oct 16. Review.

PMID:
20956084
13.

Reprogramming of somatic cells: possible methods to derive safe, clinical-grade human induced pluripotent stem cells.

Augustyniak J, Zychowicz M, Podobinska M, Barta T, Buzanska L.

Acta Neurobiol Exp (Wars). 2014;74(4):373-82. Review.

14.

Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells.

Chang MY, Kim D, Kim CH, Kang HC, Yang E, Moon JI, Ko S, Park J, Park KS, Lee KA, Hwang DY, Chung Y, Lanza R, Kim KS.

PLoS One. 2010 Mar 24;5(3):e9838. doi: 10.1371/journal.pone.0009838.

15.

Simple generation of human induced pluripotent stem cells using poly-beta-amino esters as the non-viral gene delivery system.

Montserrat N, Garreta E, González F, Gutiérrez J, Eguizábal C, Ramos V, Borrós S, Izpisua Belmonte JC.

J Biol Chem. 2011 Apr 8;286(14):12417-28. doi: 10.1074/jbc.M110.168013. Epub 2011 Feb 1.

16.

iPS cell-derived cardiogenicity is hindered by sustained integration of reprogramming transgenes.

Martinez-Fernandez A, Nelson TJ, Reyes S, Alekseev AE, Secreto F, Perez-Terzic C, Beraldi R, Sung HK, Nagy A, Terzic A.

Circ Cardiovasc Genet. 2014 Oct;7(5):667-76. doi: 10.1161/CIRCGENETICS.113.000298. Epub 2014 Jul 30.

17.

Efficient generation of rat induced pluripotent stem cells using a non-viral inducible vector.

Merkl C, Saalfrank A, Riesen N, Kühn R, Pertek A, Eser S, Hardt MS, Kind A, Saur D, Wurst W, Iglesias A, Schnieke A.

PLoS One. 2013;8(1):e55170. doi: 10.1371/journal.pone.0055170. Epub 2013 Jan 31.

18.

Integration-free methods for generating induced pluripotent stem cells.

Zhou YY, Zeng F.

Genomics Proteomics Bioinformatics. 2013 Oct;11(5):284-7. doi: 10.1016/j.gpb.2013.09.008. Epub 2013 Oct 11. Review.

19.

Optimal ratio of transcription factors for somatic cell reprogramming.

Nagamatsu G, Saito S, Kosaka T, Takubo K, Kinoshita T, Oya M, Horimoto K, Suda T.

J Biol Chem. 2012 Oct 19;287(43):36273-82. doi: 10.1074/jbc.M112.380683. Epub 2012 Sep 6.

20.

New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood.

Fujie Y, Fusaki N, Katayama T, Hamasaki M, Soejima Y, Soga M, Ban H, Hasegawa M, Yamashita S, Kimura S, Suzuki S, Matsuzawa T, Akari H, Era T.

PLoS One. 2014 Dec 5;9(12):e113052. doi: 10.1371/journal.pone.0113052. eCollection 2014.

Supplemental Content

Support Center